Net gamma exposure for Ionis Pharmaceuticals Inc (IONS) options was positive at the Nov 4, 2026 close, about $102.22K per 1% move in the stock. It has been positive on 14 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for IONS, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for IONS, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for IONS, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
IONS Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is IONS gamma exposure positive or negative?
Ionis Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $102.22K. It has been positive on 14 of the last 20 trading days.
How has IONS gamma exposure changed recently?
Ionis Pharmaceuticals net gamma exposure went from -$159.78K on Oct 7, 2026 to $102.22K on Nov 4, 2026. See the IONS gamma exposure history for a longer view.
What is Ionis Pharmaceuticals Inc?
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs.